{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:12:47Z","timestamp":1789053167594,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Society for study of Diabetes in India"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26018-9","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:22:24Z","timestamp":1764163344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Independent effects of Metformin and Dapagliflozin on Fetuin-A, hepatic and pancreatic fat, and hepatic fibrosis in Asian Indians with type 2 diabetes"],"prefix":"10.1038","volume":"15","author":[{"given":"Koel","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya Prakash","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irshad Ahmad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"12","key":"26018_CR1","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S2213-8587(18)30204-3","volume":"6","author":"AP Hills","year":"2018","unstructured":"Hills, A. P. et al. Epidemiology and determinants of type 2 diabetes in South Asia. Lancet Diabetes Endocrinol. 6 (12), 966\u2013978 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11\u201312","key":"26018_CR2","doi-asserted-by":"publisher","first-page":"103160","DOI":"10.1016\/j.dsx.2024.103160","volume":"18","author":"P Ranasinghe","year":"2024","unstructured":"Ranasinghe, P. et al. Rising trends of diabetes in South asia: A systematic review and meta-analysis. Diabetes Metab. Syndr. 18 (11\u201312), 103160 (2024).","journal-title":"Diabetes Metab. Syndr."},{"issue":"6","key":"26018_CR3","doi-asserted-by":"publisher","first-page":"102321","DOI":"10.1016\/j.dsx.2021.102321","volume":"15","author":"A Misra","year":"2021","unstructured":"Misra, A. et al. Screening for diabetes in India should be initiated at 25 years age. Diabetes Metab. Syndr. 15 (6), 102321 (2021).","journal-title":"Diabetes Metab. Syndr."},{"issue":"2","key":"26018_CR4","doi-asserted-by":"publisher","first-page":"103205","DOI":"10.1016\/j.dsx.2025.103205","volume":"19","author":"RM Parikh","year":"2025","unstructured":"Parikh, R. M. et al. Ahmedabad declaration: A framework to combat growing epidemic of young-onset type 2 diabetes in Asia. Diabetes Metab. Syndr. 19 (2), 103205 (2025).","journal-title":"Diabetes Metab. Syndr."},{"issue":"1","key":"26018_CR5","doi-asserted-by":"publisher","first-page":"102989","DOI":"10.1016\/j.dsx.2024.102989","volume":"19","author":"A Misra","year":"2025","unstructured":"Misra, A. et al. Revised definition of obesity in Asian Indians living in India. Diabetes Metab. Syndr. 19 (1), 102989 (2025).","journal-title":"Diabetes Metab. Syndr."},{"issue":"3","key":"26018_CR6","doi-asserted-by":"publisher","first-page":"103209","DOI":"10.1016\/j.dsx.2025.103209","volume":"19","author":"A Misra","year":"2025","unstructured":"Misra, A. et al. Consensus guidelines for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes. Diabetes Metab. Syndr. 19 (3), 103209 (2025).","journal-title":"Diabetes Metab. Syndr."},{"issue":"1","key":"26018_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00125-022-05803-5","volume":"66","author":"S Iliodromiti","year":"2022","unstructured":"Iliodromiti, S. et al. Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data. Diabetologia 66(1), 44\u201356 (2022).","journal-title":"Diabetologia"},{"issue":"48","key":"26018_CR8","doi-asserted-by":"publisher","first-page":"18273","DOI":"10.1073\/pnas.0608537103","volume":"103","author":"KF Petersen","year":"2006","unstructured":"Petersen, K. F. et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc. Natl. Acad. Sci. U S A. 103 (48), 18273\u201318277 (2006).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"26018_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.clnesp.2021.08.028","volume":"46","author":"A Gupta","year":"2021","unstructured":"Gupta, A., Anoop, S., Ansari, I. A., Prakash, S. & Misra, A. High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus. Clin. Nutr. ESPEN. 46, 519\u2013526 (2021).","journal-title":"Clin. Nutr. ESPEN"},{"issue":"10","key":"26018_CR10","doi-asserted-by":"publisher","first-page":"e0140447","DOI":"10.1371\/journal.pone.0140447","volume":"10","author":"A Misra","year":"2015","unstructured":"Misra, A. et al. Body fat Patterning, hepatic fat and pancreatic volume of Non-Obese Asian Indians with type 2 diabetes in North india: A Case-Control study. PLoS One. 10 (10), e0140447 (2015).","journal-title":"PLoS One"},{"key":"26018_CR11","doi-asserted-by":"publisher","first-page":"945287","DOI":"10.3389\/fcell.2022.945287","volume":"10","author":"E Chekol Abebe","year":"2022","unstructured":"Chekol Abebe, E. et al. The structure, biosynthesis, and biological roles of fetuin-A: A review. Front. Cell. Dev. Biol. 10, 945287 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"6","key":"26018_CR12","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.dsx.2020.11.015","volume":"14","author":"MS Kuchay","year":"2020","unstructured":"Kuchay, M. S., Choudhary, N. S., Mishra, S. K. & Misra, A. Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes. Diabetes Metab. Syndr. 14 (6), 2233\u20132239 (2020).","journal-title":"Diabetes Metab. Syndr."},{"issue":"6","key":"26018_CR13","doi-asserted-by":"publisher","first-page":"e2267","DOI":"10.1210\/clinem\/dgac138","volume":"107","author":"A Ghosh","year":"2022","unstructured":"Ghosh, A. et al. Dapagliflozin improves body fat Patterning, and hepatic and pancreatic fat in patients with type 2 diabetes in North India. J. Clin. Endocrinol. Metab. 107 (6), e2267\u2013e75 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"26018_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.5009\/gnl20367","volume":"15","author":"K Pinyopornpanish","year":"2021","unstructured":"Pinyopornpanish, K., Leerapun, A., Pinyopornpanish, K. & Chattipakorn, N. Effects of Metformin on hepatic steatosis in adults with nonalcoholic fatty liver disease and diabetes: insights from the cellular to patient levels. Gut Liver. 15 (6), 827\u2013840 (2021).","journal-title":"Gut Liver"},{"issue":"1","key":"26018_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbadis.2016.10.002","volume":"1863","author":"S Agarwal","year":"2017","unstructured":"Agarwal, S. et al. Fetuin-A downregulates adiponectin through Wnt-PPARgamma pathway in lipid induced inflamed adipocyte. Biochim. Biophys. Acta Mol. Basis Dis. 1863 (1), 174\u2013181 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"26018_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/jcp.30499","volume":"237","author":"A Mukhuty","year":"2022","unstructured":"Mukhuty, A., Fouzder, C. & Kundu, R. Fetuin-A excess expression amplifies lipid induced apoptosis and beta-cell damage. J. Cell. Physiol. 237 (1), 532\u2013550 (2022).","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"26018_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4093\/dmj.2018.0171","volume":"43","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Koh, W. P., Jensen, M. K., Yuan, J. M. & Pan, A. Plasma Fetuin-A levels and risk of type 2 diabetes mellitus in A Chinese population: A nested Case-Control study. Diabetes Metab. J. 43 (4), 474\u2013486 (2019).","journal-title":"Diabetes Metab. J."},{"issue":"9","key":"26018_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.metabol.2008.04.019","volume":"57","author":"K Mori","year":"2008","unstructured":"Mori, K. et al. Effects of Pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism 57 (9), 1248\u20131252 (2008).","journal-title":"Metabolism"},{"issue":"3","key":"26018_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2174\/1573399813666170112151108","volume":"14","author":"NA Sheriba","year":"2018","unstructured":"Sheriba, N. A. et al. Effect of Metformin therapy on serum fetuin levels in insulin resistant type 1 diabetics. Curr. Diabetes Rev. 14 (3), 291\u2013297 (2018).","journal-title":"Curr. Diabetes Rev."},{"issue":"1","key":"26018_CR20","doi-asserted-by":"publisher","first-page":"107747","DOI":"10.1016\/j.jdiacomp.2020.107747","volume":"35","author":"HW Lee","year":"2021","unstructured":"Lee, H. W. et al. Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after Metformin treatment for 2years. J. Diabetes Complications. 35 (1), 107747 (2021).","journal-title":"J. Diabetes Complications"},{"key":"26018_CR21","doi-asserted-by":"publisher","first-page":"8491742","DOI":"10.1155\/2017\/8491742","volume":"2017","author":"R Zhang","year":"2017","unstructured":"Zhang, R. et al. Metformin and diammonium glycyrrhizinate Enteric-Coated capsule versus Metformin alone versus diammonium glycyrrhizinate Enteric-Coated capsule alone in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus. Gastroenterol. Res. Pract. 2017, 8491742 (2017).","journal-title":"Gastroenterol. Res. Pract."},{"issue":"1","key":"26018_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/br.2012.18","volume":"1","author":"Y Li","year":"2013","unstructured":"Li, Y., Liu, L., Wang, B., Wang, J. & Chen, D. Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Biomed. Rep. 1 (1), 57\u201364 (2013).","journal-title":"Biomed. Rep."},{"issue":"5","key":"26018_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/met.2018.0086","volume":"17","author":"G Zsori","year":"2019","unstructured":"Zsori, G. et al. In New-Onset diabetes Mellitus, Metformin reduces fat accumulation in the Liver, but not in the pancreas or pericardium. Metab. Syndr. Relat. Disord. 17 (5), 289\u2013295 (2019).","journal-title":"Metab. Syndr. Relat. Disord"},{"issue":"6","key":"26018_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.repc.2018.08.010","volume":"38","author":"M Ziyrek","year":"2019","unstructured":"Ziyrek, M., Kahraman, S., Ozdemir, E. & Dogan, A. Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients. Rev. Port Cardiol. (Engl Ed). 38 (6), 419\u2013423 (2019).","journal-title":"Rev. Port Cardiol. (Engl Ed)"},{"issue":"4","key":"26018_CR25","doi-asserted-by":"publisher","first-page":"e0249491","DOI":"10.1371\/journal.pone.0249491","volume":"16","author":"C Beyer","year":"2021","unstructured":"Beyer, C. et al. Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort. PLoS One. 16 (4), e0249491 (2021).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26018-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26018-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26018-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:22:24Z","timestamp":1764163344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26018-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26018"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26018-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3456006\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have declared that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"42156"}}